Cleerly is a comprehensive, AI-driven platform designed to quantify and assess coronary artery disease (CAD), delivering clinically actionable insights through a web-based solution. The software measures plaque volume, composition, length, and location, evaluates stenosis severity in both 2D (diameter and area) and 3D (lumen and vessel volume), and includes a workflow for determining the likely presence or absence of ischemia. This approach aims to reduce the need for additional testing and enhance diagnostic confidence in heart attack prevention. The platform leverages machine learning to analyze and characterize plaque, calculate stenosis, and detect likely ischemia in specific vessels, empowering better treatment decisions and improving patient outcomes.

Features & Benefits

• AI-Enabled CCTA Solution: Provides comprehensive, accurate, and trackable insights for personalized heart attack prevention.
• Plaque Analysis: Leverages machine learning to analyze and characterize plaque, measuring volume, composition, length, and location.
• Stenosis Evaluation: Evaluates stenosis severity in 2D (diameter and area) and 3D (lumen and vessel volume).
• Ischemia Detection Workflow: Determines the likely presence or absence of ischemia, potentially reducing the need for further testing.